Seeliger B, Stahl K, David Sascha
Klinik für Pneumologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Internist (Berl). 2020 Oct;61(10):1010-1016. doi: 10.1007/s00108-020-00862-5.
Despite ongoing development, mortality in sepsis remains considerable. Various techniques for extracorporeal cytokine removal have been described, but evidence remains conflicting.
The aim of this article is to summarize currently used extracorporeal blood purification techniques and their evidence.
Non-systematic literature review RESULTS: There are currently various blood purification techniques used with different levels of evidence regarding cytokine removal, vasopressor sparing effects and reduction of mortality, including high-volume dialysis with and without high cut-off filters, special adsorption filters (including CytoSorb®, CytoSorbents Europe, Berlin, Germany, and polymyxin‑B filters). There is development regarding therapeutic plasma exchange. For some blood purification techniques such as combined plasma filtration and adsorption, multicentric randomized studies found a negative effect on survival.
Despite a theoretical rationale, the use of blood purification methods cannot be recommended for sepsis patients due to the lack of evidence of their efficacy. Heterogeneous inflammatory responses in sepsis render conduction of larger trials difficult. Thus, future studies should cautiously identify appropriate sepsis subtypes to be included. Available techniques should be chosen as individualized complementary treatments and not as competing systems.
尽管不断发展,但脓毒症的死亡率仍然很高。已经描述了多种用于体外清除细胞因子的技术,但证据仍然相互矛盾。
本文旨在总结目前使用的体外血液净化技术及其证据。
非系统性文献综述
目前有多种血液净化技术,在细胞因子清除、血管升压药节省效应和死亡率降低方面有不同程度的证据,包括使用和不使用高截留滤器的高容量透析、特殊吸附滤器(包括德国柏林的欧洲CytoSorbents公司的CytoSorb®和多粘菌素B滤器)。治疗性血浆置换也在发展中。对于一些血液净化技术,如联合血浆滤过吸附,多中心随机研究发现对生存有负面影响。
尽管有理论依据,但由于缺乏疗效证据,不建议对脓毒症患者使用血液净化方法。脓毒症中炎症反应的异质性使得进行更大规模的试验变得困难。因此,未来的研究应谨慎确定合适的脓毒症亚型纳入研究。应选择现有的技术作为个体化的辅助治疗,而不是相互竞争的系统。